by in
Entry Author Date Location
With FDA Hold Lifted, Esperion Cholesterol Drug Heads to Phase 3 02/09/15 Detroit
Esperion Therapeutics Secures $70,000,000 New Funding Round 06/26/13 Detroit
Esperion Therapeutics Raises $33M to Further Clinical Trials 04/25/13 Detroit
Esperion Therapeutics Secures $33,000,000 New Funding Round 04/25/13 Detroit
Michigan Life Sciences Roundup: Swift Biosciences, Aastrom 03/11/13 Detroit
Mayleben Ends Short-Lived Retirement to Lead Esperion 01/04/13 Detroit
Link Between Cardiovascular And Metabolic Diseases? That’s What Esperion Therapeutics Founder Has Been Trying To Tell You 06/23/11 Detroit
With Esperion Reboot, Lipitor Co-Discoverer Roger Newton Pushes For Therapy Beyond Drugs 05/25/11 Detroit
What Ever Happened To Michigan High Tech IPOs? 05/12/11 Detroit
Can’t Buy Me Love: Michigan Life Science Startups Best Cleantech In Cash, Not Attention 05/03/11 Detroit
Xconomy’s Michigan 2031 Forum: The Juice Is Worth The Squeeze 04/22/11 Detroit
Back For More: Renaissance Venture Capital Funding Arboretum Ventures III 04/19/11 Detroit
Get Set for Michigan 2031: Xconomy’s First Detroit Event to Examine State’s Innovation Landscape 20 Years Ahead 02/24/11 Detroit
Michigan’s Renaissance “Fund of Funds” Closes at Nearly $50M, Ready to Make Connections Between VCs and Entrepreneurs 09/07/10 Detroit
Five Things Michigan Entrepreneurs and Innovators Are Already Doing to Invigorate the State’s Economy 07/06/10 Detroit
Rising from the Ashes of Pfizer: The Michigan Contract Research Organization Cluster 07/01/10 Detroit
Esperion Reaches Deal With TransGenRx 06/21/10 Detroit
Esperion, Cleveland Clinic Collaborate 06/14/10 Detroit
Aastrom Biosciences Seeks to Catch Cell Therapy Wave, Ride Dendreon’s Coattails 06/02/10 Detroit
Page 1 of 1